NCAM1 and Huntington disease: In newborns, where immature ganglion cells (frequently calretinin-negative but CD56-positive) mimic endothelial or even fibroblastic cells [10], the concomitant use of CD56 and calretinin decreases the possibility of a false-positive diagnosis of HD [10,20].